Results 191 to 200 of about 1,571,974 (242)
Prospects of elafibranor in treating alcohol-associated liver diseases. [PDF]
Cui WT, Xue HR, Wei DF, Feng XY, Wang K.
europepmc +1 more source
Objective Pediatric rheumatologic diseases (PRDs) are characterized by high rates of anxiety and depression known to impact health‐related outcomes. We present guidance statements to assess and manage mental health concerns for youth with PRDs in pediatric rheumatology practice.
Natoshia R. Cunningham+21 more
wiley +1 more source
Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases. [PDF]
Perumal SK+4 more
europepmc +1 more source
Objective The increasing burden associated with low back pain (LBP) is a critical issue. This is a novel analysis of trends in risk factors for LBP aiming to identify risk factors that require further attention or consideration in global policies to reduce the burden of LBP.
Katharine E. Roberts+5 more
wiley +1 more source
Astragaloside IV as a promising therapeutic agent for liver diseases: current landscape and future perspectives. [PDF]
Chen C+9 more
europepmc +1 more source
Juvenile Idiopathic Arthritis, Earnings, and Work Loss: A Nationwide Matched Cohort Study
Objective This study compares trajectories of earnings and work loss in individuals with juvenile idiopathic arthritis (JIA) versus matched comparators from the general population. Methods Patients with JIA (n = 4,737) were identified in the Swedish National Patient Register (2001–2017) and individually matched to up to five general population ...
Heather Miller+4 more
wiley +1 more source
The role and function of lncRNA in ageing-associated liver diseases. [PDF]
Zarandi PK, Ghiasi M, Heiat M.
europepmc +1 more source